Blood cell changes may predict pancreatic cancer survival
NCT ID NCT07329920
First seen Jan 11, 2026 · Last updated May 02, 2026 · Updated 15 times
Summary
This completed study looked at 300 people with pancreatic cancer to see if changes in a certain type of tumor cell in the blood (called mesenchymal CTCs) could predict how well they respond to treatment before surgery. Researchers tracked these cells over time and compared them to survival outcomes. The goal was to find a simple blood test that helps doctors personalize treatment, but the study was observational and did not test a new treatment itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital of Naval Medical UniversityUniversity
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.